Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Brain activity during a virtual reality pathfinding task in stroke patients

Measures brain activity during a virtual reality navigation task in adults with stroke.

Plain-language title generated from the registry record
Registry title: Brain Activation Pattern Caused by Immersive Virtual Reality Pathfinding Task in Stroke Patients: an FNIRS Study

Key facts

Where
Chongqing, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT06703320, who can take part

Where in China

  • Department of Rehabilitation Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing,, Chongqing, Chongqing 400010Chongqing, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Dingqun Bai
Trial code
NCT06703320
Record updated
26 November 2024
Original description
This is an fNIRS study performed to investigate Brain Activation Pattern Caused by Immersive Virtual Reality Pathfinding Task in Stroke Patients.Read full original descriptionShow less

Brain Activation Pattern Caused by Immersive Virtual Reality Pathfinding Task in Stroke Patients: a Functional Near-infrared Spectroscopy Study

This is an fNIRS study performed to investigate Brain Activation Pattern Caused by Immersive Virtual Reality Pathfinding Task in Stroke Patients.

Inclusion: Stroke patients:; Diagnosis of stroke confirmed by neuroimaging (CT or MRI); 18-80 years old; Able to complete the cognitive task; Able to follow instructions to complete the trial; Patients who signed an informed consent form; Healthy Subjects:; No abnormalities on cranial; 18-80 years old; Able to complete cognitive task; Able to follow instructions to complete the trial; not taking medications; Subjects who signed an informed consent form.

Exclusion: Stroke patients:; Inability to tolerate the test due to organic diseases; Serious mental illness that prevents them from cooperating with or tolerating the trial; Had metal implants, a history of other neurological disorders, acute cardiopulmonary dysfunction; Healthy Subjects:; Inability to tolerate the test due to organic diseases; Serious mental illness that prevents them from cooperating with or tolerating the trial; Had metal implants, a history of other neurological disorders, acute cardiopulmonary dysfunction; Pregnant or lactating women; Pregnant or lactating women.

ClinicalTrials.gov NCT06703320